Summit Therapeutics Inc. (NASDAQ: SMMT) today announced it has entered into a clinical trial collaboration with GSK plc ("GSK ...

Decoy Therapeutics, Inc. (Nasdaq: DCOY) (Decoy, or the Company), a preclinical biopharmaceutical that is engineering the next generation of peptide conjugate therapeutics, announces that the ...

COLORADO SPRINGS, CO, UNITED STATES, January 14, 2026 /EINPresswire.com/ -- Lahjavida Bio, a biotechnology company ...

The Centers for Disease Control and Prevention (CDC) has issued updated guidance on the use of a newly licensed pentavalent ...

BluEnergies Ltd. (TSXV: BLU) ("BLU" or the "Company") is pleased to report it has successfully entered into an industry ...

Xtandi, Astellas’ roughly $6 billion prostate cancer juggernaut by annual sales, is set to lose U.S. patent protection in ...

First patient dosed in Phase 2 ASPEN-09-Breast trial evaluating evorpacept in combination with trastuzumab and physician’s ...

The FDA told influenza vaccine makers they should add a warning about an increased febrile seizure risk in babies and ...

Mandated vaccinations for children attending school will remain in place, said New York State Health Commissioner Dr. James ...

Florida Gov. Ron DeSantis said he agreed with U.S. Centers for Disease Control's reduction in recommended vaccines.

From January 12 to 15, 2026, the 44th J.P. Morgan Healthcare Conference (JPMHC) was held in San Francisco, California, USA.